A high MCV (mean corpuscular volume) means your red blood cells are larger than normal, a finding called macrocytosis. In leukemia, it most often comes from one of three sources: the disease disturbing how the bone marrow builds red cells, the side effects of treatment such as hydroxyurea or methotrexate, or a separate problem like vitamin B12 or folate deficiency. A high MCV on its own does not diagnose leukemia, but in someone with leukemia or suspected leukemia it is a useful clue that deserves an explanation.
What MCV Measures
MCV is part of the standard complete blood count (CBC). It reports the average size of a red blood cell in femtoliters (fL). The adult reference range is roughly 80 to 100 fL, with small differences between laboratories.
Red cells are made in the bone marrow. As each precursor matures, it divides several times and shrinks. When DNA synthesis is disrupted, the cells skip divisions and are released larger than usual, which is why so many marrow problems show up as a raised MCV. Our article on the role of red blood cells explains this normal process in more depth.
| MCV result | Term | Common associations |
|---|---|---|
| Below 80 fL | Microcytosis | Iron deficiency, thalassemia trait |
| 80–100 fL | Normocytic | Normal, or anemia of chronic disease, acute blood loss, many leukemias at diagnosis |
| Above 100 fL | Macrocytosis | B12 or folate deficiency, alcohol, liver disease, hypothyroidism, medications, MDS, some AML |
| Markedly high (roughly above 110–115 fL) | Marked macrocytosis | More typical of B12 or folate deficiency, myelodysplastic syndromes, or drug effects |
What Causes High MCV in Leukemia?
1. Myelodysplastic changes in the marrow
Myelodysplastic syndromes (MDS) are marrow disorders in which blood cells form abnormally, and they can progress to acute myeloid leukemia (AML). Macrocytosis is one of their classic early signs. AML that arises from MDS, or that shows myelodysplasia-related changes, also frequently produces large, misshapen red cells because the disordered bone marrow function affects red cell production too.
2. Chemotherapy and other leukemia treatments
Many drugs used in blood cancers interfere with DNA synthesis. Hydroxyurea, widely used to control high white counts in chronic myeloid leukemia and related disorders, raises the MCV in most people who take it. Methotrexate blocks folate metabolism, and drugs such as 6-mercaptopurine, cytarabine, and hypomethylating agents can also enlarge red cells. This is usually an expected effect, not a sign of relapse.
3. Vitamin B12 or folate deficiency
Poor appetite, mouth sores, nausea, and gut problems during treatment can reduce folate intake quickly, because body stores of folate last only months. B12 stores last much longer, but deficiency still occurs. Both produce megaloblastic anemia, with large red cells and characteristic changes in white cells.
4. A raised reticulocyte count
Young red cells, called reticulocytes, are larger than mature ones. When the marrow is recovering after chemotherapy, or replacing cells destroyed by autoimmune hemolytic anemia (a known complication of chronic lymphocytic leukemia), a surge of reticulocytes can push the MCV up.
5. Laboratory artifacts
Cold agglutinins, antibodies that make red cells clump at room temperature, can cause the analyzer to count clumps as single large cells and falsely raise the MCV. They are associated with some lymphoid cancers. Warming the sample and repeating the count usually resolves the question.
6. Causes unrelated to leukemia
Alcohol use, liver disease, an underactive thyroid, and medicines outside cancer care can all enlarge red cells. These need to be excluded before blaming the leukemia itself.
Symptoms and Clinical Picture
Macrocytosis itself causes no symptoms. What people feel comes from any accompanying anemia or from the leukemia:
- fatigue, weakness, and breathlessness,
- pale skin,
- easy bruising or bleeding when platelets are low,
- frequent infections when normal white cells are reduced,
- fevers, night sweats, or unexplained weight loss in some leukemias.
B12 deficiency can add numbness or tingling in the feet and hands, balance problems, or a sore, smooth tongue. These neurological symptoms need prompt treatment.
How Doctors Investigate a High MCV
A single high MCV is interpreted alongside the rest of the blood count, medicines, and history. A typical workup includes:
- Repeat CBC to confirm the result and check hemoglobin, white cells, and platelets.
- Peripheral blood smear to look for oval macrocytes, hypersegmented neutrophils (suggesting B12 or folate deficiency), dysplastic cells, or blasts.
- Reticulocyte count to see whether new red cell production is high or low.
- Vitamin B12 and folate levels, plus liver and thyroid tests.
- Medication review, especially hydroxyurea, methotrexate, and other chemotherapy.
- Bone marrow aspirate and biopsy when the cause is unclear, when other counts are abnormal, or when MDS or leukemia is suspected. Cytogenetic and molecular tests on the marrow classify the disease.
In someone already being treated for leukemia, a new rise in MCV with falling counts may prompt a marrow check to distinguish drug effect from disease change. These abnormal blood findings always need to be read in context.
Treatment and Management
High MCV is managed by treating its cause rather than the number itself.
- Leukemia or MDS: the underlying disease is treated with chemotherapy, targeted drugs, hypomethylating agents, or stem cell transplant, depending on the diagnosis. As normal marrow recovers, red cell size often normalizes.
- Treatment-related macrocytosis: usually needs no action if hemoglobin is adequate. Hydroxyurea-related macrocytosis is expected and is not a reason to stop the drug.
- B12 or folate deficiency: replacement with injections or tablets, with the cause of deficiency addressed. Folinic acid is used as planned “rescue” after certain methotrexate regimens.
- Symptomatic anemia: red cell transfusion when needed, as part of supportive care for leukemia side effects.
Research in hematology continues to clarify how specific genetic changes in MDS and AML affect red cell development. For broader context on these diseases, see our leukemia guide.
Key Takeaways
- MCV above about 100 fL means red cells are enlarged; it is a clue, not a diagnosis.
- In leukemia, common causes are myelodysplastic changes, chemotherapy effects, vitamin deficiencies, and reticulocytosis.
- A blood smear, reticulocyte count, and B12 and folate levels sort out most cases; a bone marrow test answers the rest.
- Management targets the cause, and many treatment-related cases need no specific action.
- Any unexplained high MCV with other abnormal counts deserves review by a specialist in hematological disease.
Frequently Asked Questions
Does a high MCV mean I have leukemia?
No. Most people with a high MCV do not have leukemia; alcohol, B12 or folate deficiency, liver disease, thyroid problems, and medicines are far more common causes. A high MCV with low platelets, abnormal white cells, or blasts on the smear is more concerning and needs prompt review.
Which leukemias are linked to high MCV?
Macrocytosis is most closely linked with myelodysplastic syndromes and AML with myelodysplasia-related changes. Many other leukemias are normocytic at diagnosis, although treatment or complications can later raise the MCV.
Why did my MCV go up on hydroxyurea?
Hydroxyurea slows DNA synthesis in developing blood cells, so red cells come out larger. This is expected and is sometimes used as a sign that the drug is being taken regularly. It is not usually harmful on its own.
Can high MCV go back to normal?
Often, yes. It usually falls once a vitamin deficiency is corrected, a responsible drug is stopped, or the marrow recovers with treatment. Because red cells live about 120 days, the change takes a few months to show.
